Huntington’s disease (HD) is a genetic neurodegenerative disorder that affects the basal ganglia, resulting in a range of symptoms such as movement difficulties, cognitive decline, and psychiatric disturbances. Unfortunately, there is no known cure for HD, and current treatments only address the symptoms rather than the underlying disease process. However, recent research has shown that medicinal marijuana may hold promise in managing some of the symptoms of HD.

Medical cannabis, which contains compounds called cannabinoids, has been found to have neuroprotective properties and can help alleviate some of the symptoms associated with HD. 

One study published in the Journal of Huntington’s Disease in 2020 found that medical marijuana can improve the quality of life in patients with HD. The study found that medical cannabis was effective in reducing some of the psychiatric symptoms associated with HD, such as depression, anxiety, and irritability. Additionally, the study found that medicinal cannabis was well-tolerated by patients with HD, with no significant adverse effects reported.

Another study published in the Journal of Clinical Psychopharmacology in 2021 found that medicinal marijuana may improve motor symptoms in patients with HD. The study found that THC-containing medical cannabis was associated with significant improvements in motor function and overall disease severity in patients with HD.

Overall, the use of medical cannabis in managing HD symptoms shows promise, and further research is needed to fully understand its potential. However, the studies conducted so far suggest that medical cannabis may provide a safe and effective treatment option for patients with HD.

If you or anyone you know is interested in starting the medical marijuana certification process, consult a physician today.